Genomic Epidemiology of SARS-CoV-2

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".

Deadline for manuscript submissions: closed (15 July 2023) | Viewed by 1805

Special Issue Editor


E-Mail Website
Guest Editor
Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
Interests: molecular epidemiology; precision medicine; pharmacogenetics; pharmacogenomics; SARS-CoV-2 genomic surveillance

Special Issue Information

Dear Colleagues,

Tracking viral diversity has been useful in understanding viral evolution, transmission dynamics, clinical manifestations and reinfections; and in subsidizing public health policy. The SARS-CoV-2 pandemic has led to an unprecedented viral genomic surveillance effort and increased global sequencing capacity. Although more than 1000 lineages have already been described, SARS-CoV-2 diversity gained major focus after the World Health Organization designated the variants of interest (VOIs) and variants of concern (VOCs). A Special Issue of Genes entitled “Genomic Epidemiology of SARS-CoV-2” is receiving manuscripts exploring the epidemiological aspects of SARS-CoV-2 diversity and its impacts throughout the pandemic.

Dr. Renan Pedra De Souza
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • genomic surveillance
  • SARS-CoV-2 variants
  • variants of concern
  • viral diversity
  • phylogeography
  • molecular epidemiology
  • transmission dynamics
  • next-generation sequencing

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 1527 KiB  
Article
Development and Application of Real-Time PCR-Based Screening for Identification of Omicron SARS-CoV-2 Variant Sublineages
by Anna Esman, Dmitry Dubodelov, Kamil Khafizov, Ivan Kotov, German Roev, Anna Golubeva, Gasan Gasanov, Marina Korabelnikova, Askar Turashev, Evgeniy Cherkashin, Konstantin Mironov, Anna Cherkashina and Vasily Akimkin
Genes 2023, 14(6), 1218; https://doi.org/10.3390/genes14061218 - 02 Jun 2023
Viewed by 1439
Abstract
The Omicron strain is currently the main dominant variant of SARS-CoV-2, with a large number of sublineages. In this article, we present our experience in tracing it in Russia using molecular diagnostic methods. For this purpose, different approaches were used; for example, we [...] Read more.
The Omicron strain is currently the main dominant variant of SARS-CoV-2, with a large number of sublineages. In this article, we present our experience in tracing it in Russia using molecular diagnostic methods. For this purpose, different approaches were used; for example, we developed multiprimer panels for RT-PCR and Sanger and NGS sequencing methods. For the centralized collection and analysis of samples, the VGARus database was developed, which currently includes more than 300,000 viral sequences. Full article
(This article belongs to the Special Issue Genomic Epidemiology of SARS-CoV-2)
Show Figures

Figure 1

Back to TopTop